CoChat
Sign Up
Cited by 171

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

New models for analyzing mast cell functions in vivo

Reber, Laurent L., Marichal, Thomas, Galli, Stephen J.·2012·Trends in Immunology
DOI 10.1016/j.it.2012.09.008PMC PMC3572764
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.it.2012.09.008

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 137

  1. Oka, 2012, Evidence questioning cromolyn's effectiveness and selectivity as a ‘mast cell stabilizer’ in mice, Lab. Invest., 92, 1472, 10.1038/labinvest.2012.116 · DOI
  2. Oliveira, 2003, Stem cell factor: a hemopoietic cytokine with important targets in asthma, Curr. Drug Targets Inflamm. Allergy, 2, 313, 10.2174/1568010033483990 · DOI
  3. Reber, 2006, Stem cell factor and its receptor c-Kit as targets for inflammatory diseases, Eur. J. Pharmacol., 533, 327, 10.1016/j.ejphar.2005.12.067 · DOI
  4. Kitamura, 1989, Heterogeneity of mast cells and phenotypic change between subpopulations, Annu. Rev. Immunol., 7, 59, 10.1146/annurev.iy.07.040189.000423 · DOI
  5. Galli, 2005, Mast cells as “tunable” effector and immunoregulatory cells: recent advances, Annu. Rev. Immunol., 23, 749, 10.1146/annurev.immunol.21.120601.141025 · DOI · Paper page
  6. Grimbaldeston, 2005, Mast cell-deficient W-sash c-kit mutant KitW-sh/W-sh mice as a model for investigating mast cell biology in vivo, Am. J. Pathol., 167, 835, 10.1016/S0002-9440(10)62055-X · DOI · Paper page
  7. Dawicki, 2007, New and emerging roles for mast cells in host defence, Curr. Opin. Immunol., 19, 31, 10.1016/j.coi.2006.11.006 · DOI · Paper page
  8. Piliponsky, 2010, Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice, Am. J. Pathol., 176, 926, 10.2353/ajpath.2010.090342 · DOI
  9. Galli, 2005, Mast cells in the development of adaptive immune responses, Nat. Immunol., 6, 135, 10.1038/ni1158 · DOI
  10. Grimbaldeston, 2006, Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses, Curr. Opin. Immunol., 18, 751, 10.1016/j.coi.2006.09.011 · DOI
  11. Grimbaldeston, 2007, Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B, Nat. Immunol., 8, 1095, 10.1038/ni1503 · DOI
  12. Zhou, 2007, Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis, J. Exp. Med., 204, 2797, 10.1084/jem.20071391 · DOI
  13. Hayashi, 1991, Exon skipping by mutation of an authentic splice site of c-kit gene in W/W mouse, Nucleic Acids Res., 19, 1267, 10.1093/nar/19.6.1267 · DOI
  14. Nocka, 1990, Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W, EMBO J., 9, 1805, 10.1002/j.1460-2075.1990.tb08305.x · DOI
  15. Nagle, 1995, Physical mapping of the Tec and Gabrb1 loci reveals that the Wsh mutation on mouse chromosome 5 is associated with an inversion, Hum. Mol. Genet., 4, 2073, 10.1093/hmg/4.11.2073 · DOI
  16. Nigrovic, 2008, Genetic inversion in mast cell-deficient Wsh mice interrupts corin and manifests as hematopoietic and cardiac aberrancy, Am. J. Pathol., 173, 1693, 10.2353/ajpath.2008.080407 · DOI · Paper page
  17. Tsai, 2005, Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo, Chem. Immunol. Allergy, 87, 179, 10.1159/000087644 · DOI
  18. Chervenick, 1969, Decreased neutrophils and megakaryocytes in anemic mice of genotype W/Wv, J. Cell. Physiol., 73, 25, 10.1002/jcp.1040730104 · DOI
  19. Feyerabend, 2011, Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity, Immunity, 35, 832, 10.1016/j.immuni.2011.09.015 · DOI
  20. Lantz, 1998, Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites, Nature, 392, 90, 10.1038/32190 · DOI
  21. Nakano, 1985, J. Exp. Med., 162, 1025, 10.1084/jem.162.3.1025 · DOI · Paper page
  22. Martin, 1993, Mast cell activation enhances airway responsiveness to methacholine in the mouse, J. Clin. Invest., 91, 1176, 10.1172/JCI116277 · DOI
  23. Tanzola, 2003, Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course, J. Immunol., 171, 4385, 10.4049/jimmunol.171.8.4385 · DOI
  24. Wolters, 2005, Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient KitW-sh/KitW-sh sash mice, Clin. Exp. Allergy, 35, 82, 10.1111/j.1365-2222.2005.02136.x · DOI · Paper page
  25. Otsu, 1987, Phenotypic changes of bone marrow-derived mast cells after intraperitoneal transfer into W/Wv mice that are genetically deficient in mast cells, J. Exp. Med., 165, 615, 10.1084/jem.165.3.615 · DOI
  26. Scholten, 2008, Mast cell-specific Cre/loxP-mediated recombination in vivo, Transgenic Res., 17, 307, 10.1007/s11248-007-9153-4 · DOI
  27. Feyerabend, 2009, Deletion of Notch1 converts pro-T cells to dendritic cells and promotes thymic B cells by cell-extrinsic and cell-intrinsic mechanisms, Immunity, 30, 67, 10.1016/j.immuni.2008.10.016 · DOI
  28. Lilla, 2011, Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice, Blood, 118, 6930, 10.1182/blood-2011-03-343962 · DOI · Paper page
  29. Müsch, 2008, Generation and characterization of alpha-chymase-Cre transgenic mice, Genesis, 46, 163, 10.1002/dvg.20378 · DOI
  30. Dudeck, 2011, Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens, Immunity, 34, 973, 10.1016/j.immuni.2011.03.028 · DOI
  31. Voehringer, 2008, Homeostasis and effector function of lymphopenia-induced “memory-like” T cells in constitutively T cell-depleted mice, J. Immunol., 180, 4742, 10.4049/jimmunol.180.7.4742 · DOI
  32. Gordon, 1990, Phorbol 12-myristate 13-acetate-induced development of functionally active mast cells in W/Wv but not Sl/Sld genetically mast cell-deficient mice, Blood, 75, 1637, 10.1182/blood.V75.8.1637.1637 · DOI
  33. Ando, 1993, J. Clin. Invest., 92, 1639, 10.1172/JCI116749 · DOI
  34. Schmidt-Supprian, 2007, Vagaries of conditional gene targeting, Nat. Immunol., 8, 665, 10.1038/ni0707-665 · DOI
  35. Serafin, 1987, Carboxypeptidase A in mouse mast cells. Identification, characterization, and use as a differentiation marker, J. Immunol., 139, 3771, 10.4049/jimmunol.139.11.3771 · DOI
  36. Voehringer, 2004, Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production, Immunity, 20, 267, 10.1016/S1074-7613(04)00026-3 · DOI
  37. Franco, 2010, Distinguishing mast cell and granulocyte differentiation at the single-cell level, Cell Stem Cell, 6, 361, 10.1016/j.stem.2010.02.013 · DOI
  38. Steimer, 2009, Selective roles for antiapoptotic MCL-1 during granulocyte development and macrophage effector function, Blood, 113, 2805, 10.1182/blood-2008-05-159145 · DOI
  39. Zhou, 1998, Mcl-1 in transgenic mice promotes survival in a spectrum of hematopoietic cell types and immortalization in the myeloid lineage, Blood, 92, 3226, 10.1182/blood.V92.9.3226 · DOI
  40. Wershil, 1987, 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells, J. Immunol., 139, 2605, 10.4049/jimmunol.139.8.2605 · DOI
  41. Takeishi, 1991, J. Clin. Invest., 88, 598, 10.1172/JCI115344 · DOI
  42. Miyajima, 1997, Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis, J. Clin. Invest., 99, 901, 10.1172/JCI119255 · DOI
  43. Mukai, 2005, Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells, Immunity, 23, 191, 10.1016/j.immuni.2005.06.011 · DOI
  44. Newlands, 1995, Stem cell factor contributes to intestinal mucosal mast cell hyperplasia in rats infected with Nippostrongylus brasiliensis or Trichinella spiralis, but anti-stem cell factor treatment decreases parasite egg production during N. brasiliensis infection, Blood, 86, 1968, 10.1182/blood.V86.5.1968.bloodjournal8651968 · DOI · Paper page
  45. Brandt, 2003, Mast cells are required for experimental oral allergen-induced diarrhea, J. Clin. Invest., 112, 1666, 10.1172/JCI19785 · DOI
  46. Gekara, 2008, Mast cells initiate early anti-Listeria host defences, Cell. Microbiol., 10, 225
  47. Czechowicz, 2007, Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches, Science, 318, 1296, 10.1126/science.1149726 · DOI
  48. Buch, 2005, A Cre-inducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration, Nat. Methods, 2, 419, 10.1038/nmeth762 · DOI
  49. Sawaguchi, 2012, Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness, J. Immunol., 188, 1809, 10.4049/jimmunol.1101746 · DOI
  50. Otsuka, 2011, Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity, PLoS ONE, 6, e25538, 10.1371/journal.pone.0025538 · DOI
  51. Yagi, 2007, Regulation of the Il4 gene is independently controlled by proximal and distal 3′ enhancers in mast cells and basophils, Mol. Cell. Biol., 27, 8087, 10.1128/MCB.00631-07 · DOI
  52. Furumoto, 2011, PTEN deficiency in mast cells causes a mastocytosis-like proliferative disease that heightens allergic responses and vascular permeability, Blood, 118, 5466, 10.1182/blood-2010-09-309955 · DOI
  53. Gerbaulet, 2011, Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit, Blood, 117, 2012, 10.1182/blood-2008-11-189605 · DOI
  54. Sharma, 2012, SH2 domain-containing phosphatase 2 is a critical regulator of connective tissue mast cell survival and homeostasis in mice, Mol. Cell. Biol., 32, 2653, 10.1128/MCB.00308-12 · DOI
  55. Muzumdar, 2007, A global double-fluorescent Cre reporter mouse, Genesis, 45, 593, 10.1002/dvg.20335 · DOI · Paper page
  56. Haff, 1994, Improved quantitative PCR using nested primers, PCR Methods Appl., 3, 332, 10.1101/gr.3.6.332 · DOI
  57. Galli, 1984, Unequivocal delayed hypersensitivity in mast cell-deficient and beige mice, Science, 226, 710, 10.1126/science.6494907 · DOI
  58. Bryce, 2004, Immune sensitization in the skin is enhanced by antigen-independent effects of IgE, Immunity, 20, 381, 10.1016/S1074-7613(04)00080-9 · DOI
  59. Brown, 2012, Mast cells are important modifiers of autoimmune disease: With so much evidence, why is there still controversy?, Front. Immunol., 3, 147, 10.3389/fimmu.2012.00147 · DOI
  60. Rodewald, 2012, Widespread immunological functions of mast cells: fact or fiction?, Immunity, 37, 13, 10.1016/j.immuni.2012.07.007 · DOI · Paper page
  61. Akahoshi, 2011, Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice, J. Clin. Invest., 121, 4180, 10.1172/JCI46139 · DOI · Paper page
  62. Gilfillan, 2011, Regulation of mast cell responses in health and disease, Crit. Rev. Immunol., 31, 475, 10.1615/CritRevImmunol.v31.i6.30 · DOI
  63. Ribatti, 2011, Mast cells, angiogenesis and cancer, Adv. Exp. Med. Biol., 716, 270, 10.1007/978-1-4419-9533-9_14 · DOI
  64. Kennelly, 2011, Mast cells in tissue healing: from skin to the gastrointestinal tract, Curr. Pharm. Des., 17, 3772, 10.2174/138161211798357854 · DOI
  65. Galli, 2008, Immunomodulatory mast cells: negative, as well as positive, regulators of immunity, Nat. Rev. Immunol., 8, 478, 10.1038/nri2327 · DOI
  66. Abraham, 2010, Mast cell-orchestrated immunity to pathogens, Nat. Rev. Immunol., 10, 440, 10.1038/nri2782 · DOI · Paper page
  67. Supajatura, 2002, Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity, J. Clin. Invest., 109, 1351, 10.1172/JCI0214704 · DOI
  68. Schneider, 2007, Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin, J. Exp. Med., 204, 2629, 10.1084/jem.20071262 · DOI · Paper page
  69. Metz, 2006, Mast cells can enhance resistance to snake and honeybee venoms, Science, 313, 526, 10.1126/science.1128877 · DOI · Paper page
  70. Enoksson, 2011, Mast cells as sensors of cell injury through IL-33 recognition, J. Immunol., 186, 2523, 10.4049/jimmunol.1003383 · DOI
  71. Lunderius-Andersson, 2012, Mast cells respond to cell injury through the recognition of IL-33, Front. Immunol., 3, 82, 10.3389/fimmu.2012.00082 · DOI
  72. Schäfer, B. et al. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. J. Allergy Clin. Immunol. (in press).
  73. Fantozzi, 1985, Mast cell and neutrophil interactions: a role for superoxide anion and histamine, Agents Actions, 16, 260, 10.1007/BF01983155 · DOI
  74. Gri, 2008, CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction, Immunity, 29, 771, 10.1016/j.immuni.2008.08.018 · DOI
  75. Gaudenzio, 2009, Cell-cell cooperation at the T helper cell/mast cell immunological synapse, Blood, 114, 4979, 10.1182/blood-2009-02-202648 · DOI
  76. Hill, 1996, Stem cell factor enhances immunoglobulin E-dependent mediator release from cultured rat bone marrow-derived mast cells: activation of previously unresponsive cells demonstrated by a novel ELISPOT assay, Immunology, 87, 326, 10.1046/j.1365-2567.1996.455545.x · DOI
  77. Ito, 2012, Stem cell factor programs the mast cell activation phenotype, J. Immunol., 188, 5428, 10.4049/jimmunol.1103366 · DOI
  78. Galli, 1994, The kit ligand, stem cell factor, Adv. Immunol., 55, 1, 10.1016/S0065-2776(08)60508-8 · DOI
  79. Komai-Koma, 2012, Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naive mice, Allergy, 67, 1118, 10.1111/j.1398-9995.2012.02859.x · DOI
  80. Okayama, 2000, Expression of a functional high-affinity IgG receptor, FcγRI, on human mast cells: up-regulation by IFN-γ, J. Immunol., 164, 4332, 10.4049/jimmunol.164.8.4332 · DOI
  81. Baccari, 2011, Mast cells in nonmammalian vertebrates: an overview, Int. Rev. Cell Mol. Biol., 290, 1, 10.1016/B978-0-12-386037-8.00006-5 · DOI
  82. Galli, 2011, Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils, Nat. Immunol., 12, 1035, 10.1038/ni.2109 · DOI · Paper page
  83. Bowie, 2007, Steel factor responsiveness regulates the high self-renewal phenotype of fetal hematopoietic stem cells, Blood, 109, 5043, 10.1182/blood-2006-08-037770 · DOI
  84. Ikuta, 1992, Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation, Proc. Natl. Acad. Sci. U.S.A., 89, 1502, 10.1073/pnas.89.4.1502 · DOI
  85. Ogawa, 1991, Expression and function of c-kit in hemopoietic progenitor cells, J. Exp. Med., 174, 63, 10.1084/jem.174.1.63 · DOI
  86. Galli, 1995, Regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor, Int. Arch. Allergy Immunol., 107, 51, 10.1159/000236928 · DOI
  87. Okayama, 2006, Development, migration, and survival of mast cells, Immunol. Res., 34, 97, 10.1385/IR:34:2:97 · DOI
  88. Tsai, 1991, Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor, Proc. Natl. Acad. Sci. U.S.A., 88, 6382, 10.1073/pnas.88.14.6382 · DOI
  89. Tsai, 1991, The rat c-kit ligand, stem cell factor, induces the development of connective tissue-type and mucosal mast cells in vivo. Analysis by anatomical distribution, histochemistry, and protease phenotype, J. Exp. Med., 174, 125, 10.1084/jem.174.1.125 · DOI
  90. Oliveira, 2002, Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis, Blood, 100, 4291, 10.1182/blood.V100.13.4291 · DOI
  91. Krishnamoorthy, 2008, Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma, Nat. Med., 14, 565, 10.1038/nm1766 · DOI
  92. Heinemann, 2005, Stem cell factor stimulates the chemotaxis, integrin upregulation, and survival of human basophils, J. Allergy Clin. Immunol., 116, 820, 10.1016/j.jaci.2005.06.008 · DOI
  93. Manova, 1990, Gonadal expression of c-kit encoded at the W locus of the mouse, Development, 110, 1057, 10.1242/dev.110.4.1057 · DOI
  94. Manova, 1991, Expression of c-kit encoded at the W locus of mice in developing embryonic germ cells and presumptive melanoblasts, Dev. Biol., 146, 312, 10.1016/0012-1606(91)90233-S · DOI
  95. Huizinga, 1995, W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity, Nature, 373, 347, 10.1038/373347a0 · DOI
  96. Milenkovic, 2007, Nociceptive tuning by stem cell factor/c-Kit signaling, Neuron, 56, 893, 10.1016/j.neuron.2007.10.040 · DOI
  97. Takagi, 2008, Involvement of stem cell factor and its receptor tyrosine kinase c-kit in pain regulation, Neuroscience, 153, 1278, 10.1016/j.neuroscience.2008.02.073 · DOI
  98. Peters, 2003, KIT is expressed by epithelial cells in vivo, J. Invest. Dermatol., 121, 976, 10.1046/j.1523-1747.2003.12478.x · DOI
  99. Stokman, 2010, Stem cell factor expression after renal ischemia promotes tubular epithelial survival, PLoS ONE, 5, e14386, 10.1371/journal.pone.0014386 · DOI
  100. Cozzi, 2011, The naive airway hyperresponsiveness of the A/J mouse is KIT-mediated, Proc. Natl. Acad. Sci. U.S.A., 108, 12787, 10.1073/pnas.1106582108 · DOI
  101. Wiener, 2001, Highly reduced peritoneal mast cell number and decreased c-kit expression in histidine decarboxylase knock out mice, Inflamm. Res., 50, S55, 10.1007/PL00022406 · DOI
  102. Ohtsu, 2001, Mice lacking histidine decarboxylase exhibit abnormal mast cells, FEBS Lett., 502, 53, 10.1016/S0014-5793(01)02663-1 · DOI
  103. Wastling, 1998, Histochemical and ultrastructural modification of mucosal mast cell granules in parasitized mice lacking the β-chymase, mouse mast cell protease-1, Am. J. Pathol., 153, 491, 10.1016/S0002-9440(10)65592-7 · DOI
  104. Younan, 2010, The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5, J. Immunol., 185, 7681, 10.4049/jimmunol.1002803 · DOI
  105. Tchougounova, 2003, The chymase, mouse mast cell protease 4, constitutes the major chymotrypsin-like activity in peritoneum and ear tissue. A role for mouse mast cell protease 4 in thrombin regulation and fibronectin turnover, J. Exp. Med., 198, 423, 10.1084/jem.20030671 · DOI
  106. Stevens, 1996, Transgenic mice that possess a disrupted mast cell protease 5 (mMCP-5) gene can not store carboxypeptidase A (mMC-CPA) protein in their granules, FASEB J., 10, 17772
  107. Abonia, 2005, Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle, J. Immunol., 174, 7285, 10.4049/jimmunol.174.11.7285 · DOI
  108. Thakurdas, 2007, The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections, J. Biol. Chem., 282, 20809, 10.1074/jbc.M611842200 · DOI
  109. Shin, 2008, Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of trichinella spiralis infection, J. Immunol., 180, 4885, 10.4049/jimmunol.180.7.4885 · DOI
  110. Hunt, 1996, Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse, J. Biol. Chem., 271, 2851, 10.1074/jbc.271.5.2851 · DOI
  111. Feyerabend, 2005, Loss of histochemical identity in mast cells lacking carboxypeptidase A, Mol. Cell. Biol., 25, 6199, 10.1128/MCB.25.14.6199-6210.2005 · DOI
  112. Humphries, 1999, Heparin is essential for the storage of specific granule proteases in mast cells, Nature, 400, 769, 10.1038/23481 · DOI
  113. Forsberg, 1999, Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme, Nature, 400, 773, 10.1038/23488 · DOI
  114. Kung, 1995, Mast cells modulate allergic pulmonary eosinophilia in mice, Am. J. Respir. Cell Mol. Biol., 12, 404, 10.1165/ajrcmb.12.4.7695919 · DOI
  115. Takeda, 1997, Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice, J. Exp. Med., 186, 449, 10.1084/jem.186.3.449 · DOI
  116. Kobayashi, 2000, An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model, J. Immunol., 164, 3855, 10.4049/jimmunol.164.7.3855 · DOI
  117. Williams, 2000, Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice, J. Exp. Med., 192, 455, 10.1084/jem.192.3.455 · DOI
  118. Yu, 2006, Mast cells can promote the development of multiple features of chronic asthma in mice, J. Clin. Invest., 116, 1633, 10.1172/JCI25702 · DOI
  119. Nakae, 2007, Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice, J. Allergy Clin. Immunol., 120, 48, 10.1016/j.jaci.2007.02.046 · DOI
  120. Becker, 2011, Genetic variation determines mast cell functions in experimental asthma, J. Immunol., 186, 7225, 10.4049/jimmunol.1100676 · DOI
  121. Lee, 2002, Mast cells: a cellular link between autoantibodies and inflammatory arthritis, Science, 297, 1689, 10.1126/science.1073176 · DOI
  122. Elliott, 2011, Deletion of Syk in neutrophils prevents immune complex arthritis, J. Immunol., 187, 4319, 10.4049/jimmunol.1100341 · DOI
  123. Mancardi, 2011, Cutting edge: the murine high-affinity IgG receptor FcγRIV is sufficient for autoantibody-induced arthritis, J. Immunol., 186, 1899, 10.4049/jimmunol.1003642 · DOI
  124. Secor, 2000, Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis, J. Exp. Med., 191, 813, 10.1084/jem.191.5.813 · DOI
  125. Bennett, 2009, Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis, J. Immunol., 182, 5507, 10.4049/jimmunol.0801485 · DOI
  126. Li, 2011, Kit(W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression, J. Immunol., 187, 274, 10.4049/jimmunol.1003603 · DOI
  127. Piconese, 2011, Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice, Lab. Invest., 91, 627, 10.1038/labinvest.2011.3 · DOI
  128. Askenase, 1983, Defective elicitation of delayed-type hypersensitivity in W/Wv and Sl/Sld mast cell-deficient mice, J. Immunol., 131, 2687, 10.4049/jimmunol.131.6.2687 · DOI
  129. Biedermann, 2000, Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2, J. Exp. Med., 192, 1441, 10.1084/jem.192.10.1441 · DOI
  130. Norman, 2008, Mast cells regulate the magnitude and the cytokine microenvironment of the contact hypersensitivity response, Am. J. Pathol., 172, 1638, 10.2353/ajpath.2008.070559 · DOI
  131. Abt, 2009, The intestinal microbiota in health and disease: the influence of microbial products on immune cell homeostasis, Curr. Opin. Gastroenterol., 25, 496, 10.1097/MOG.0b013e328331b6b4 · DOI
  132. Hill, 2012, Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation, Nat. Med., 18, 538, 10.1038/nm.2657 · DOI · Paper page
  133. Finkelman, 2007, Anaphylaxis: lessons from mouse models, J. Allergy Clin. Immunol., 120, 506, 10.1016/j.jaci.2007.07.033 · DOI · Paper page
  134. Nigrovic, 2007, Synovial mast cells: role in acute and chronic arthritis, Immunol. Rev., 217, 19, 10.1111/j.1600-065X.2007.00506.x · DOI
  135. Mekori, 1985, Undiminished immunologic tolerance to contact sensitivity in mast cell-deficient W/Wv and Sl/Sld mice, J. Immunol., 135, 879, 10.4049/jimmunol.135.2.879 · DOI
  136. Mekori, 1987, Cell. Immunol., 109, 39, 10.1016/0008-8749(87)90290-5 · DOI
  137. Yu, 2011, Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma, J. Clin. Invest., 121, 3133, 10.1172/JCI43598 · DOI

Cited by

Sorted by citations

Metadata

Authors
Reber, L. L., Marichal, T., & Galli, S. J.
Venue
Trends in Immunology
Publisher
Elsevier BV
Published
2012-12
Volume
33
Issue
12
Pages
613-625
ISSN
1471-4906
DOI
10.1016/j.it.2012.09.008
PMC
PMC3572764
Cited by
171
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review